Toru Natsume
Papers
1
Total Citations
23
H-Index
1
About
Toru Natsume is a pioneering researcher at the intersection of genomics, epigenetics, and clinical diagnostics. His work centers on developing innovative methods to analyze chromatin from challenging biological samples, particularly formalin-fixed paraffin-embedded (FFPE) tissues—a vast, underutilized resource in clinical archives. His landmark 2021 study introduced a novel approach using a dual-arm robot to perform genome-wide chromatin immunoprecipitation and sequencing (ChIP-seq) on FFPE samples, demonstrating that these tissues retain accurate transcription factor binding sites. This breakthrough, which has garnered 23 citations, opens the door for large-scale retrospective studies of gene regulation directly from patient biopsies, bridging basic epigenomic research and clinical application. Natsume’s contributions are notable for their potential to transform how we study diseases like cancer, where FFPE samples are abundant but historically difficult to analyze at the chromatin level. His work exemplifies a commitment to translating cutting-edge genomic tools into practical, clinically relevant solutions, making him a key figure in the future of precision medicine and epigenomic diagnostics.
Research Focus
Key Achievements
Top Papers
- 1